Catherine Maari
Innovaderm (Canada)(CA)Integrated Nonclinical Development Solutions (United States)(US)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Autoimmune Bullous Skin Diseases
Most-Cited Works
- → Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial(2020)460 cited
- → A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin(2018)271 cited
- → GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis(2019)214 cited
- → Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis(2020)204 cited
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → A Prospective Randomized Trial Comparing the Efficacy and Adverse Effects of Four Recognized Treatments of Molluscum Contagiosum in Children(2006)133 cited